Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.
Collaboration brings together charity, university and pharmaceutical sectorsLandmark, launching today, is a three-year research partnership that aims ...
Shares of GSK PLC GSK inched down 0.55% to £15.28 Monday, on what proved to be an all-around favorable trading session for ...
New Mechanistic Insights Underscore Multiple Potential Roles for Elraglusib as an Immune Modulator in the treatment of NeuroblastomaStudy ...
Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...
There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...
The former head of vaccine R&D at GSK has pulled together $100 million for a London-based biotech working on respiratory ...
Tickets sold out so quickly for today’s Labour party conference “business day” that it was dubbed the corporate equivalent of ...
comments a Future Market Insights analyst. Zydus Healthcare Ltd., Sun Pharmaceutical Industries Ltd., Sanofi SA, GSK Plc, ...
Peripheral blood mononuclear cells (PBMCs) collected from 10 patients with active AS patients were exposed to TP, GSK-J4 or vehicle. T lymphocyte subsets were analyzed using flow cytometry. ELISA was ...